Cite
Image-Guided Biopsy for Relapsed Neuroblastoma: Focus on Safety, Adequacy for Genetic Sequencing, and Correlation of Tumor Cell Percent With Quantitative Lesion MIBG Uptake.
MLA
Samoyedny, Andrew, et al. “Image-Guided Biopsy for Relapsed Neuroblastoma: Focus on Safety, Adequacy for Genetic Sequencing, and Correlation of Tumor Cell Percent With Quantitative Lesion MIBG Uptake.” JCO Precision Oncology, vol. 5, May 2021, pp. 275–85. EBSCOhost, https://doi.org/10.1200/PO.20.00171.
APA
Samoyedny, A., Srinivasan, A., States, L., Mosse, Y. P., Alai, E., Pawel, B., Pogoriler, J., Shellikeri, S., Vatsky, S., Acord, M., Escobar, F., Edgar, J. C., Maris, J. M., & Cahill, A. M. (2021). Image-Guided Biopsy for Relapsed Neuroblastoma: Focus on Safety, Adequacy for Genetic Sequencing, and Correlation of Tumor Cell Percent With Quantitative Lesion MIBG Uptake. JCO Precision Oncology, 5, 275–285. https://doi.org/10.1200/PO.20.00171
Chicago
Samoyedny, Andrew, Abhay Srinivasan, Lisa States, Yael P. Mosse, Emma Alai, Bruce Pawel, Jennifer Pogoriler, et al. 2021. “Image-Guided Biopsy for Relapsed Neuroblastoma: Focus on Safety, Adequacy for Genetic Sequencing, and Correlation of Tumor Cell Percent With Quantitative Lesion MIBG Uptake.” JCO Precision Oncology 5 (May): 275–85. doi:10.1200/PO.20.00171.